KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $144.0 million.

  • Bausch Health Companies' Change in Accured Expenses changed negligibly% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $232.0 million, marking a year-over-year decrease of 46.05%. This contributed to the annual value of $357.0 million for FY2024, which is 125.95% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Change in Accured Expenses is $144.0 million, which was down 11.66% from $163.0 million recorded in Q2 2025.
  • Over the past 5 years, Bausch Health Companies' Change in Accured Expenses peaked at $166.0 million during Q3 2023, and registered a low of -$170.0 million during Q4 2021.
  • Its 3-year average for Change in Accured Expenses is $65.7 million, with a median of $97.0 million in 2023.
  • Per our database at Business Quant, Bausch Health Companies' Change in Accured Expenses plummeted by 308.70% in 2022 and then skyrocketed by 737.50% in 2024.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Change in Accured Expenses stood at -$170.0 million in 2021, then soared by 127.65% to $47.0 million in 2022, then spiked by 106.38% to $97.0 million in 2023, then tumbled by 75.26% to $24.0 million in 2024, then remained steady at $144.0 million in 2025.
  • Its Change in Accured Expenses was $144.0 million in Q3 2025, compared to $163.0 million in Q2 2025 and -$99.0 million in Q1 2025.